Digital Therapeutics Market

Request for customization Inquire Before Buying

Digital Therapeutics Market Size, Share and Industry Analysis Report By Application (Prediabetes, Nutrition, Care, Diabetes Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS), Disease Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), Substance Abuse and Rehabilitation); By Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer and Pharma) - Forecast Year 2024 – 2031

Healthcare // Healthcare IT

Number of Pages: 268 Report Format: pdf Report ID: ZBA-885 Publishing Date: - August, 2023

Frequently Ask Question

The Global Digital Therapeutics Market Is Forecasted To Grow At A Rate Of 32.4% To USD 39.57 Billion In 2030.

Key Factors That Are Driving The Market Growth Include Increasing incidence of preventable chronic diseases, Rising focus on preventive healthcare, Need to control healthcare costs

The Digital Therapeutics Market Is Led By Preventive Applications Segment And Is Projected To Account For The Largest Size Of The Digital Therapeutics Market From 2023 To 2030.

Some Key Players Operating In The Digital Therapeutics Market Include 2Morrow, Akili, Ayogo, Behavr, Better Therapeutics, Canary Health, Click Therapeutics, Cognifit, Cognoa, Freespira, Ginger, Hinge Health, Kaia Health, Mindable Health, Mindstrong Health, Noom, Omada Health, Orexo Ab, Pear Therapeutics, Propeller Health, Teladoc Health, Twill, Virta Health Corp, Welldoc, Wellthy Therapeutics